Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Dowlais Group (DWL) by Jefferies
- Buy Norcros (NXR) by Berenberg
- Buy Volex (VLX) by Tom Winnifrith in ShareProphets
- Buy Volex (VLX) by Steve Moore in ShareProphets
- Buy Origin Enterprises (CDI) (OGN) by Shore Capital
- Buy Victorian Plumbing Group (VIC) by Shore Capital
- Avoid Cropper (James) (CRPR) by Steve Moore in ShareProphets
- Buy Close Brothers Group (CBG) by Shore Capital
- Buy WH Smith (SMWH) by Canaccord Genuity
- Hold Halma (HLMA) by Shore Capital
- Buy Speedy Hire (SDY) by Canaccord Genuity
- Buy Norcros (NXR) by Shore Capital
- Buy XPS Pensions Group (XPS) by Canaccord Genuity
- Hold CMC Markets (CMCX) by Shore Capital
- Hold Warehouse Reit (WHR) by Shore Capital
- Buy Jet2 (JET2) by Canaccord Genuity
- Underperform Halma (HLMA) by Jefferies
- Avoid Churchill China (CHH) by Steve Moore in ShareProphets
- Buy Sage Group (SGE) by Bank of America
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
Maxcyte (DI) (MXCT) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Maxcyte (DI) (MXCT)
| Latest Bid : 262.00p | Latest Ask : 270.00p |
| High Today : 268.73p | Low Today : 262.00p |
| This Years High : 420.00p | This Years Low : 262.00p |
| Volume : 38,592 | MKT Cap : £279.3M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Maxcyte (DI) (MXCT) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.Maxcyte (DI) (MXCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | 8.57% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -26.11% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -36.67% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -61.96% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -70.00% |
Maxcyte (DI) (MXCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 262.00p | Latest Ask : 270.00p |
| High Today : 268.73p | Low Today : 262.00p |
| This Years High : 420.00p | This Years Low : 262.00p |
| Volume : 38,592 | MKT Cap : £279.3M |
Maxcyte (DI) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Maxcyte (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | 8.57% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -26.11% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -36.67% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -61.96% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -70.00% |